Comparison of the Efficacy and Safety of Latanoprost 0.005% Compared to Brimonidine 0.2% or Dorzolamide 2% When Added to a Topical β-Adrenergic Blocker in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
STEWART, WILLIAM C., SHARPE, ELIZABETH D., DAY, DOUGLAS G., KOLKER, ALLAN E., KONSTAS, ANASTASIOS G.P., LEE, WILLIAM H., RIESER, JOHN C., CHOPRA, HERSH, HOLMES, KERI T.Volume:
16
Language:
english
Journal:
Journal of Ocular Pharmacology and Therapeutics
DOI:
10.1089/jop.2000.16.251
Date:
June, 2000
File:
PDF, 859 KB
english, 2000